Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy

Abstract

Purpose A substantial proportion of breast cancer survivors report significant, long-lasting impairments in cognitive function, often referred to as "chemobrain." Advances in detection and treatment mean that many more patients are surviving long-term following diagnosis of invasive breast cancer. Thus, it is important to define the types, extent, and persistence of cognitive impairments following treatment with cytotoxic cancer drugs. Experimental design We examined the effects of chronic treatment with two agents commonly used in patients with breast cancer, cyclophosphamide and doxorubicin (Adriamycin). Athymic nude rats were given 50 mg/kg cyclophosphamide, 2 mg/kg doxorubicin, or saline injections once per week for 4 weeks. A novel place recognition task and contextual and cued fear conditioning were used to characterize learning and memory ability. Immunofluorescence staining for immature and mature neurons and activated microglia was used to assess changes in neurogenesis and neuroinflammation. Results Cyclophosphamide- and doxorubicin-treated rats showed significantly impaired performance on the novel place recognition task and the contextual fear conditioning task compared with untreated controls, suggesting disrupted hippocampal-based memory function. Chemotherapy-treated animals showed a significant decline in neurogenesis [80%-90% drop in bromodeoxyuridine (BrdUrd)-labeled cells expressing NeuN]. Activated microglia (ED1-positive) were found after cyclophosphamide…

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-11-2000

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Cited by

See all 335

Metadata

Authors
Christie, L.-A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L.
Affiliations
University of California, Irvine (US)
Venue
Clinical Cancer Research
Published
2012-04-01
Volume
18
Issue
7
Pages
1954-1965
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2102451894
Cited by
311
References
45
Citations by year
2026: 20 · 2025: 22 · 2024: 24 · 2023: 21 · 2022: 23 · 2021: 38 · 2020: 26 · 2019: 19 · 2018: 17 · 2017: 24 · 2016: 23 · 2015: 16 · 2014: 17 · 2013: 15 · 2012: 6
FWCI
13.92
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Directorate for Biological Sciences
  • U.S. Public Health Service (U19A1067769)
  • University of California, Irvine
  • National Institute of Allergy and Infectious Diseases
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
Keywords
chemobrain, chemotherapy-induced cognitive impairment, breast cancer, cyclophosphamide, doxorubicin, hippocampal neurogenesis, neuroinflammation, microglial activation, fear conditioning, learning and memory, long-term cancer survivors
MeSH terms
Analysis of Variance, Animals, Antineoplastic Agents, Body Weight, Breast Neoplasms, Bromodeoxyuridine, Cognition Disorders, Conditioning, Psychological, Cyclophosphamide, Doxorubicin, Fear, Female, Fluorescent Antibody Technique, Hippocampus, Humans, Learning, Male, Memory, Motor Activity, Neurons, Rats, Nude, Rats, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-11-2000
The paper
Christie, L.-A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L. (2012). Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-11-2000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.